Bipolar Disorder Research Program, Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Cambridge, Massachusetts, USA
Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013–24.CalabreseJRBowdenCLSachsGet alA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.J Clin Psychiatry2003641013-24Q What are the effects of lamotrigine and lithium for maintenance treatment in recently depressed people with bipolar I disorder?
For correspondence: J Calabrese, University Hospitals of Cleveland/Case Western Reserve School of Medicine, Department of Psychiatry, Cleveland, Ohio, USA; [email protected]
Sources of funding: GlaxoSmithKline, Abbott Laboratories, Bristol-Myers Squibb, GlaxoWellcome, Janssen, Lilly Research, the National Institute of Mental Health, Parke-Davis, R.W. Johnson Pharmaceutical Institute, Smith Kline Beecham, the Stanley Foundation, Eli Lilly, Solvay, Novartis, Sanofi, Astra Zeneca, and Pfizer.
